Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.


Treating the Common Dyslipidemia in Patients with Type 2 Diabetes—Insights from FIELD on the Effects of Fenofibrate on CVD Risk


US Cardiology 2006;3(1):21–6

Treating Atherogenic Dyslipidemia in Patients with Type 2 Diabetes—The Case for Using Fenofibrate


US Cardiology 2005;2(1):39–43

Treatment of Type 2 Diabetes with a Combination of Two Insulin Sensitizers — Increased Efficacy and Fewer Side-effects


US Cardiology 2004;1(1):1–4

Upstream Treatments for Atrial Fibrillation


US Cardiology 2007;4(1):20–2